Graft-Versus-Host Disease (GVHD) Clinical Trials

A listing of Graft-Versus-Host Disease (GVHD) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 241 clinical trials
Lipopolysaccharide Metabolism and Identification of Potential Biomarkers Predictive of Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

(PLTP) activity and these both biological variables are independent variables for predicting the risk of severe Graft versus Host Disease (GVHD).

cell transplantation
remission
hematologic malignancy
graft versus host disease
myeloablative conditioning
  • 1 views
  • 03 Feb, 2021
  • 2 locations
Multidisciplinary Intervention In Chronic GVHD

quality of life, symptom burden and psychological distress of adults who received an allogeneic hematopoietic stem cell transplant and developed graft versus-host disease (GVHD).

chronic graft versus host disease
allogeneic hematopoietic stem cell transplant
graft versus host disease
  • 0 views
  • 10 Sep, 2021
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation

tocilizumab, an IL-6 receptor monoclonal antibody, to improve immune reconstitution and reduce relapse while preserving low rates of graft failure and graft versus host disease (GVHD).

remission
karnofsky performance status
lymphoma
graft versus host disease
blood disorder
  • 0 views
  • 26 Jan, 2021
  • 1 location
A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

  • 9 views
  • 08 Mar, 2021
  • 1 location
Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease

the clinic, or Hydrosun 575home for home treatment) in patients with morphea or sclerotic GVHD (Graft-versus-host Disease). The purpose of the study is to determine whether wIRA irradiation can reduce

  • 0 views
  • 21 Jul, 2021
  • 2 locations
T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

graft versus host disease (GVHD) based on standard classification of acute and chronic GVHD - Improving hte disease remission rate in comparison with our previous study results

remission
donor lymphocyte infusion
serum bilirubin level
graft versus host disease
myeloid leukemia
  • 35 views
  • 07 Nov, 2020
  • 1 location
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy

severe chronic graft-versus-host disease (GVHD) following hematopoietic stem cell transplantation. GVHD occurs when the cells from your donor (the graft) see your body's cells (the host) as different and

blast crisis
cell transplantation
hematologic malignancy
lymphoma
abatacept
  • 0 views
  • 13 Mar, 2021
  • 1 location
Co-transplantation of MSC in the Setting of Allo-HSCT

hematopoietic stem cell transplantation (allo-HSCT) .The study is aimed to identify and evaluate the potential benefits of MSCs infusion during allogeneic HSCT, with regard to the engraftment, graft versus host

ejection fraction
graft versus host disease
  • 2 views
  • 23 Jan, 2021
  • 1 location
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients

administration of a resistant starch is capable of increasing levels of butyrate within the intestine that will reduce rates of acute GVHD (Graft-Versus-Host Disease).

acute graft-versus-host disease
graft versus host disease
cancer
  • 4 views
  • 28 Jan, 2021
  • 1 location
Allo HSCT Using RIC for Hematological Diseases

primary objective is to evaluate rates of acute graft-versus-host disease (GVHD) grades II-IV and chronic GVHD with an updated GVHD prophylaxis of tacrolimus and mycophenolate mofetil (MMF) with a non

neutrophil count
remission
plasma cell leukemia
myeloproliferative syndromes
anemia
  • 27 views
  • 31 May, 2021
  • 1 location